Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Chopra

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|November 9, 2004
Comparison of assays for detection of agents causing membrane damage in Staphylococcus aureusAlexander John O'Neill, Keith Miller, Brunello Oliva, et al.
Nature Reviews. Microbiology|June 17, 2010
Structure-based discovery of antibacterial drugsKatie J Simmons, Ian Chopra, Colin W G Fishwick
The Journal of Antimicrobial Chemotherapy|May 20, 2004
Assessment of a microplate method for determining the post-antibiotic effect in Staphylococcus aureus and Escherichia coliWilliam J Stubbings, Julieanne M Bostock, Eileen Ingham, et al.
The Journal of Antimicrobial Chemotherapy|August 2, 2008
Consequences of daptomycin-mediated membrane damage in Staphylococcus aureusJoanne Karen Hobbs, Keith Miller, Alex John O'Neill, et al.
The Journal of Antimicrobial Chemotherapy|February 6, 2004
Anti-staphylococcal activity and mode of action of clofazimineBrunello Oliva, Alexander John O'Neill, Keith Miller, et al.
Archives of Microbiology|January 11, 2012
Biochemical characterisation of the chlamydial MurF ligase, and possible sequence of the chlamydial peptidoglycan pentapeptide stemDelphine Patin, Julieanne Bostock, Ian Chopra, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolatesAlexander J O'Neill, Anders R Larsen, Anne S Henriksen, et al.
Journal of Bacteriology|October 13, 2009
Functional and biochemical analysis of the Chlamydia trachomatis ligase MurEDelphine Patin, Julieanne Bostock, Didier Blanot, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2012
The target of daptomycin is absent from Escherichia coli and other gram-negative pathogensChristopher P Randall, Katherine R Mariner, Ian Chopra, et al.
Nature Reviews. Microbiology|December 18, 2010
Targeting bacterial membrane function: an underexploited mechanism for treating persistent infectionsJulian G Hurdle, Alex J O'Neill, Ian Chopra, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|November 9, 2004
Comparison of assays for detection of agents causing membrane damage in Staphylococcus aureusAlexander John O'Neill, Keith Miller, Brunello Oliva, et al.
Nature Reviews. Microbiology|June 17, 2010
Structure-based discovery of antibacterial drugsKatie J Simmons, Ian Chopra, Colin W G Fishwick
The Journal of Antimicrobial Chemotherapy|May 20, 2004
Assessment of a microplate method for determining the post-antibiotic effect in Staphylococcus aureus and Escherichia coliWilliam J Stubbings, Julieanne M Bostock, Eileen Ingham, et al.
The Journal of Antimicrobial Chemotherapy|August 2, 2008
Consequences of daptomycin-mediated membrane damage in Staphylococcus aureusJoanne Karen Hobbs, Keith Miller, Alex John O'Neill, et al.
The Journal of Antimicrobial Chemotherapy|February 6, 2004
Anti-staphylococcal activity and mode of action of clofazimineBrunello Oliva, Alexander John O'Neill, Keith Miller, et al.
Archives of Microbiology|January 11, 2012
Biochemical characterisation of the chlamydial MurF ligase, and possible sequence of the chlamydial peptidoglycan pentapeptide stemDelphine Patin, Julieanne Bostock, Ian Chopra, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolatesAlexander J O'Neill, Anders R Larsen, Anne S Henriksen, et al.
Journal of Bacteriology|October 13, 2009
Functional and biochemical analysis of the Chlamydia trachomatis ligase MurEDelphine Patin, Julieanne Bostock, Didier Blanot, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2012
The target of daptomycin is absent from Escherichia coli and other gram-negative pathogensChristopher P Randall, Katherine R Mariner, Ian Chopra, et al.
Nature Reviews. Microbiology|December 18, 2010
Targeting bacterial membrane function: an underexploited mechanism for treating persistent infectionsJulian G Hurdle, Alex J O'Neill, Ian Chopra, et al.
Pageof 6